Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 19.

Ceccon, Garry, Lazaridis, Lazaros, Stoffels, Gabriele ORCID: 0000-0001-7114-1941, Rapp, Marion, Weber, Manuel, Blau, Tobias, Lohmann, Phillip, Kebir, Sied, Herrmann, Ken, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Glas, Martin and Galldiks, Norbert ORCID: 0000-0002-2485-1796 (2018). Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience. Eur. J. Nucl. Med. Mol. Imaging, 45 (9). S. 1626 - 1636. NEW YORK: SPRINGER. ISSN 1619-7089

Galldiks, Norbert ORCID: 0000-0002-2485-1796, Dunkl, Veronika, Stoffels, Gabriele, Hutterer, Markus, Rapp, Marion, Kebir, Sied, Goldbrunner, Roland, Ruge, Maximilian I., Schmidt, Matthias and Langen, Karl-Josef (2014). DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Galldiks, Norbert ORCID: 0000-0002-2485-1796, Dunkl, Veronika, Stoffels, Gabriele ORCID: 0000-0001-7114-1941, Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska ORCID: 0000-0001-9093-8307, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter ORCID: 0000-0003-3894-5053, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Drzezga, Alexander, Schmidt, Matthias and Langen, Karl-Josef ORCID: 0000-0003-1101-5075 (2015). Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[F-18]fluoroethyl)-L-tyrosine PET. Eur. J. Nucl. Med. Mol. Imaging, 42 (5). S. 685 - 696. NEW YORK: SPRINGER. ISSN 1619-7089

Galldiks, Norbert ORCID: 0000-0002-2485-1796, Dunkl, Veronika, Stoffels, Gabriele ORCID: 0000-0001-7114-1941, Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska ORCID: 0000-0001-9093-8307, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter ORCID: 0000-0003-3894-5053, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Drzezga, Alexander, Schmidt, Matthias and Langen, Karl-Josef ORCID: 0000-0003-1101-5075 (2015). Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[F-18]fluoroethyl)-L-tyrosine PET. Eur. J. Nucl. Med. Mol. Imaging, 42 (5). S. 685 - 696. NEW YORK: SPRINGER. ISSN 1619-7089

Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Haenel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Ruediger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tuettenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter and Glas, Martin (2016). Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. J. Clin. Oncol., 34 (14). S. 1611 - 1623. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim, Schlegel, Uwe, Sabel, Michael, Hau, Peter, Kortman, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Tabatabai, Ghazaleh, Ringel, Florian, Schmidt-Graf, Friederike, Brehmer, Stefanie, Weyerbrock, Astrid, Bullinger, Lars, Vajkoczy, Peter, Vatter, Hartmut, Schaefer, Niklas, Kebir, Sied, Weller, Johannes, Stummer, Walter, Simon, Matthias, Keil, Vera ORCID: 0000-0001-8699-3506, Nelles, Michael, Fimmers, Rolf, Pietsch, Torsten, Hattingen, Elke, Coch, Christoph and Glas, Martin (2017). PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. Neuro-Oncology, 19. S. 13 - 15. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Herrlinger, Ulrich, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter ORCID: 0000-0003-3894-5053, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schaefer, Niklas, Kebir, Sied, Weller, Johannes ORCID: 0000-0001-5818-5392, Schaub, Christina, Stummer, Walter, Tonn, Joerg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang ORCID: 0000-0002-6171-634X, Weller, Michael, Fimmers, Rolf, Schmid, Matthias ORCID: 0000-0002-0788-0317, Hattingen, Elke ORCID: 0000-0002-8392-9004, Pietsch, Torsten, Coch, Christoph and Glas, Martin (2019). Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. Lancet, 393 (10172). S. 678 - 689. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Kebir, Sied, Fimmers, Rolf, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schaefer, Niklas, Mack, Frederic, Schaub, Christina, Stuplich, Moritz, Niessen, Michael, Tzaridis, Theophilos, Simon, Matthias, Stoffels, Gabriele ORCID: 0000-0001-7114-1941, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Scheffler, Bjoern, Glas, Martin and Herrlinger, Ulrich (2016). Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[F-18]fluoroethyl)-L-Tyrosine PET. Clin. Cancer Res., 22 (9). S. 2190 - 2197. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Kebir, Sied, Hattingen, Elke, Schaub, Christina, Schafer, Niklas, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Tzaridis, Theophilos, Baehr, Oliver, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich (2016). EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. Neuro-Oncology, 18. S. 5 - 6. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Niessen, Michael, Kellner, Alexandra, Tschuschke, Volker, Herrlinger, Ulrich and Glas, Martin (2017). ACTIVE COPING STRATEGIES ARE ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: A PROSPECTIVE STUDY. Neuro-Oncology, 19. S. 208 - 209. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Rauschenbach, Laurel, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schlaak, Max, Hattingen, Elke ORCID: 0000-0002-8392-9004, Landsberg, Jennifer ORCID: 0000-0001-8029-3883, Bundschuh, Ralph A., Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Scheffler, Bjoern, Herrlinger, Ulrich and Glas, Martin (2016). Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases. Neuro-Oncology, 18 (10). S. 1462 - 1465. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Weller, Johannes ORCID: 0000-0001-5818-5392, Mack, Frederic, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Baehr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich (2019). Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. J. Neuro-Oncol., 144 (3). S. 501 - 510. NEW YORK: SPRINGER. ISSN 1573-7373

Kebir, Sied, Schmidt, Teresa, Weber, Matthias, Lazaridis, Lazaros, Galldiks, Norbert, Langen, Karl-Josef, Kleinschnitz, Christoph, Hattingen, Elke, Herrlinger, Ulrich, Lohmann, Philipp and Glas, Martin (2020). MACHINE LEARNING-BASED EVALUATION OF STATIC AND DYNAMIC FET-PET FOR THE DETECTION OF PSEUDOPROGRESSION IN PATIENTS WITH IDH-WILDTYPE GLIOBLASTOMA. Neuro-Oncology, 22. S. 149 - 152. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Kebir, Sied, Schmidt, Teresa, Weber, Matthias, Lazaridis, Lazaros, Galldiks, Norbert, Langen, Karl-Josef ORCID: 0000-0003-1101-5075, Kleinschnitz, Christoph, Hattingen, Elke, Herrlinger, Ulrich, Lohmann, Philipp ORCID: 0000-0002-5360-046X and Glas, Martin (2020). A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma. Cancers, 12 (11). BASEL: MDPI. ISSN 2072-6694

Kebir, Sied, Stummer, Walter, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Proescholdt, Martin, Vatter, Hartmut, Herrlinger, Ulrich and Glas, Martin (2017). COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA: RESULTS FROM THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 235 - 236. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Schaefer, Niklas, Proescholdt, Martin, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Grau, Stefan, Haenel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Niessen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin and Herrlinger, Ulrich (2018). Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology, 20 (7). S. 975 - 986. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Baehr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich and Glas, Martin (2018). Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J. Cancer Res. Clin. Oncol., 144 (8). S. 1581 - 1590. NEW YORK: SPRINGER. ISSN 1432-1335

Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Schaefer, Niklas, Weller, Johannes, Steinbach, Joachim-Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Joerg-Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich and Felsberg, Joerg . MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial. Int. J. Cancer. HOBOKEN: WILEY. ISSN 1097-0215

Weller, Johannes ORCID: 0000-0001-5818-5392, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich and Schaefer, Niklas (2019). Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol., 20 (10). S. 1444 - 1454. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

This list was generated on Fri Apr 16 06:02:11 2021 CEST.